ScienceDex / Researcher record
Karen P. Usdin
- National Institute of Diabetes and Digestive and Kidney Diseases (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2025
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2025): $2.3M in linked award amounts across 2 award records · Award-linked rank #5180.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2025 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6570353Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2025 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2025 award records by amount
NIH award records listing Karen P. Usdin as a PI. Multi-PI records show the full award amount for context.
- 1ZIADK057808-19ZIAContact PIUnderstanding the mutational mechanism responsible for the Repeat Expansion Diseases$1.3Maward amount
- 1ZIADK057602-29ZIAContact PIThe consequences of the unusual mutation responsible for the Repeat Expansion Diseases$1Maward amount
Award organization
Organizations that administered FY2025 awards listing Karen P. Usdin as a PI.
FY2025 award administered by National Institute of Diabetes and Digestive and Kidney Diseases ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2025First NIH AwardNational Institute of Diabetes and Digestive and Kidney Diseases
- 2025$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #5180